Search Results - "Alatorre, Carlos I"

Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis by Edson-Heredia, Emily, Sterling, Kimberly L., Alatorre, Carlos I., Cuyun Carter, Gebra, Paczkowski, Rosirene, Zarotsky, Victoria, Maeda-Chubachi, Tomoko

“…Psoriasis treatment responses are affected by patient characteristics. However, the literature does not contain reviews of factors that affect the response to…”
Get full text

Inaccurate Reporting of Insulin Reimbursement by Alatorre, Carlos I, Schultz, Eric H

Get more information

COMPREHENSIVE REVIEW OF FACTORS IMPLICATED IN THE HETEROGENEITY OF RESPONSE IN DEPRESSION by Carter, Gebra Cuyún, Cantrell, Ronald A, Victoria Zarotsky, Haynes, Virginia S, Phillips, Glenn, Alatorre, Carlos I, Goetz, Iris, Paczkowski, Rosirene, Marangell, Lauren B

“…Background Heterogeneity in overall response and outcomes to pharmacological treatment has been reported in several depression studies but with few sources…”
Get full text

Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control by Alatorre, Carlos I., Hoogwerf, Byron J., Deeg, Mark A., Nelson, David R., Hunter, Theresa M., Ng, Wee Teck, Rekhter, Mark D.

“…Objectives: The objective of this study was to identify factors associated with stroke, myocardial infarction (MI), all-cause mortality, or a diagnosis of…”
Get full text

Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine by Molife, Cliff, Haynes, Virginia S., Nyhuis, Allen, Faries, Douglas E., Gelwicks, Steve, Kelsey, Douglas K., Alatorre, Carlos I.

“…Objectives: To compare 1-year direct healthcare costs and utilization among children and adolescents initiating non-stimulant medications atomoxetine (ATX) or…”
Get full text

Review of treatment response in rheumatoid arthritis: assessment of heterogeneity by Goetz, Iris, Carter, Gebra Cuyún, Lucero, Melanie, Zarotsky, Victoria, Alatorre, Carlos I., Cantrell, Ronald A., Paczkowski, Rosirene, Sterling, Kimberly L.

“…Abstract Objective: Rheumatoid arthritis (RA) is a chronic, systemic, progressive, inflammatory disorder. The primary goals of treatment in RA are to reduce…”
Get full text

Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison by Alatorre, Carlos I., Haynes, Virginia, Faries, Douglas, Upadhyaya, Himanshu, Kelsey, Douglas

Get full text

COMPREHENSIVE REVIEW OF FACTORS IMPLICATED IN THE HETEROGENEITY OF RESPONSE IN DEPRESSION: Review: Heterogeneity in Depression by Carter, Gebra Cuyún, Cantrell, Ronald A, Victoria Zarotsky, Haynes, Virginia S, Phillips, Glenn, Alatorre, Carlos I, Goetz, Iris, Paczkowski, Rosirene, Marangell, Lauren B

Get full text

Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison/Authors' Reply to Alatorre et al.: "Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison" by Alatorre, Carlos I, Haynes, Virginia, Faries, Douglas, Upadhyaya, Himanshu, Kelsey, Douglas, Erder, M Haim, Xie, Jipan, Signorovitch, James E, Chen, Kristina S, Hodgkins, Paul, Lu, Mei, Wu, Eric Q, Sikirica, Vanja

Get full text